This inventor holds 1 USPTO granted patent. Top assignee: Laboratoires Fournier Sa. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Andrew McCreary: Innovator in Parkinson's Disease Treatment
Introduction
Andrew McCreary is a notable inventor based in Almere, Netherlands. He has made significant contributions to the field of medical research, particularly in the treatment of Parkinson's disease. His innovative work focuses on the use of indole derivatives as NURR-1 activators.
Latest Patents
McCreary holds a patent for the "Use of indole derivatives as NURR-1 activators for treating Parkinson's disease." This invention relates to a compound derived from indole, specifically a therapeutically useful compound characterized by its selection from compounds of formula (I). This advancement has the potential to improve treatment options for individuals suffering from this debilitating condition.
Career Highlights
Andrew McCreary is associated with Laboratoires Fournier SA, where he has been instrumental in advancing research and development in pharmacology. His work has garnered attention for its innovative approach to addressing complex medical challenges.
Collaborations
McCreary has collaborated with notable colleagues, including Benaïssa Boubia and Johannes Bernard Van Vliet. These partnerships have contributed to the success of his research endeavors and the development of effective therapeutic solutions.
Conclusion
In summary, Andrew McCreary is a dedicated inventor whose work in the field of Parkinson's disease treatment showcases his commitment to medical innovation. His contributions are paving the way for new therapeutic strategies that could significantly enhance patient care.